Literature DB >> 23436406

Western blot evaluation of siRNA delivery by pH-responsive peptides.

Wanling Liang1, A James Mason, Jenny K W Lam.   

Abstract

Gene silencing, via RNA interference (RNAi) technologies using small interfering RNA (siRNA), has been developed as an important tool for target identification and validation in drug discovery and has huge therapeutic potential. However, effective delivery into cells presents a major challenge to the use of siRNA. pH-responsive cell-penetrating peptides have attracted considerable attention in recent years as delivery vectors due to their ability to transport their cargos across the biological membrane and/or to promote endosomal escape and prevent lysosomal degradation. To evaluate the in vitro transfection efficiency of the pH-responsive peptide-based siRNA delivery system, the western blotting technique is commonly employed. This method offers a simple, efficient and economical way to study the gene silencing effect of the siRNA by analysing the protein of interest in a sample with minimum equipment requirement. This chapter provides a description of siRNA delivery and analysis by western blotting protocols for qualitatively and quantitatively assessing gene silencing efficiency and selectivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436406      PMCID: PMC3631761          DOI: 10.1007/978-1-62703-311-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Gene silencing in mammals by small interfering RNAs.

Authors:  Michael T McManus; Phillip A Sharp
Journal:  Nat Rev Genet       Date:  2002-10       Impact factor: 53.242

Review 2.  Staying on message: design principles for controlling nonspecific responses to siRNA.

Authors:  Shirley Samuel-Abraham; Joshua N Leonard
Journal:  FEBS J       Date:  2010-12       Impact factor: 5.542

Review 3.  Endosomal escape pathways for delivery of biologicals.

Authors:  Amir K Varkouhi; Marije Scholte; Gert Storm; Hidde J Haisma
Journal:  J Control Release       Date:  2010-11-13       Impact factor: 9.776

Review 4.  Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.

Authors:  Bryan R Meade; Steven F Dowdy
Journal:  Adv Drug Deliv Rev       Date:  2007-03-15       Impact factor: 15.470

Review 5.  Cationic amphipathic histidine-rich peptides for gene delivery.

Authors:  Antoine Kichler; A James Mason; Burkhard Bechinger
Journal:  Biochim Biophys Acta       Date:  2006-02-28

Review 6.  siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.

Authors:  Sunit Kumar Singh; Praveensingh B Hajeri
Journal:  Drug Discov Today       Date:  2009-06-21       Impact factor: 7.851

7.  Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.

Authors:  Bérangère Langlet-Bertin; Christian Leborgne; Daniel Scherman; Burkhard Bechinger; A James Mason; Antoine Kichler
Journal:  Pharm Res       Date:  2010-07       Impact factor: 4.200

Review 8.  RNAi screening for the discovery of novel modulators of human disease.

Authors:  Attila A Seyhan; Terence E Rya
Journal:  Curr Pharm Biotechnol       Date:  2010-11       Impact factor: 2.837

9.  Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.

Authors:  Jenny K W Lam; Wanling Liang; Yun Lan; Poulami Chaudhuri; Michael Y T Chow; Katarzyna Witt; Laila Kudsiova; A James Mason
Journal:  J Control Release       Date:  2011-11-26       Impact factor: 9.776

  9 in total
  6 in total

1.  Cationic Dendrimers for siRNA Delivery: An Overview of Methods for In Vitro/In Vivo Characterization.

Authors:  Erik Laurini; Suzana Aulic; Domenico Marson; Maurizio Fermeglia; Sabrina Pricl
Journal:  Methods Mol Biol       Date:  2021

2.  Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.

Authors:  Roberto Mota; Jessica E Rodríguez; Andrea Bonetto; Thomas M O'Connell; Scott A Asher; Traci L Parry; Pamela Lockyer; Christopher R McCudden; Marion E Couch; Monte S Willis
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

3.  The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6.

Authors:  Betty Lau; Emma Poole; Benjamin Krishna; Immaculada Sellart; Mark R Wills; Eain Murphy; John Sinclair
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

4.  Chaperonin-Dendrimer Conjugates for siRNA Delivery.

Authors:  Martin G Nussbaumer; Jason T Duskey; Martin Rother; Kasper Renggli; Mohamed Chami; Nico Bruns
Journal:  Adv Sci (Weinh)       Date:  2016-05-27       Impact factor: 16.806

5.  Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src.

Authors:  Nabila Brahami; Selvakumar Subramaniam; Moudjahed Saleh Al-Ddafari; Cecile Elkaim; Pierre-Olivier Harmand; Badr-Eddine Sari; Gérard Lefranc; Mourad Aribi
Journal:  J Negat Results Biomed       Date:  2017-03-20

6.  Transfection types, methods and strategies: a technical review.

Authors:  Zhi Xiong Chong; Swee Keong Yeap; Wan Yong Ho
Journal:  PeerJ       Date:  2021-04-21       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.